SCHEMBL7978734

SCHEMBL7978734

C=C(c1ccccn1)N(C[C]=O)C(=O)/C=C/c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.52
RAB9A P51151 5/20 0.52
PKM P14618 4/20 0.52
MAPT P10636 4/20 0.52
KDM4E B2RXH2 3/20 0.52
LMNA P02545 3/20 0.52
SMN1; SMN2 Q16637 3/20 0.44
TRPM8 Q7Z2W7 4/20 0.41
ALDH1A1 P00352 3/20 0.41
L3MBTL1 Q9Y468 4/20 0.41
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
GAA P10253 1/20 0.39
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7975656 0.81 KDM4E (0.42) NPC1RAB9APKMMAPTKDM4E
SCHEMBL7746460 0.78 NPC1 (0.51) NPC1RAB9APKMMAPTKDM4E
SCHEMBL7746933 0.78 DHODH (0.47) NPC1RAB9APKMMAPTKDM4E
SCHEMBL7746930 0.78 DHODH (0.47) NPC1RAB9APKMMAPTKDM4E
SCHEMBL7746456 0.78 NPC1 (0.51) NPC1RAB9APKMMAPTKDM4E
SCHEMBL7747215 0.78 TRPM8 (0.48) NPC1RAB9APKMMAPTKDM4E
SCHEMBL7749657 0.78 NPC1 (0.53) NPC1MAPTLMNASMN1; SMN2TRPM8
SCHEMBL7749651 0.78 NPC1 (0.53) NPC1MAPTLMNASMN1; SMN2TRPM8
SCHEMBL7746488 0.77 KMT2A (0.52) NPC1RAB9APKMMAPTKDM4E
SCHEMBL7746484 0.77 KMT2A (0.52) NPC1RAB9APKMMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6194396-B1 ANTIALLERGENS; ANTIINFLAMMATION AGENTS; AUTOIMMUNE DISEASE; ANTISHOCK AGENTS; ANALGESICS; E.G., A 4 OR 7-PHENYLALKYLENE-OXYBENZIMIDAZOLE UNSUBSTITUTED OR SUBSTITUTED IN THE 1,2,3-POSITION WITH AN OXY, AMINO AND/OR THIO GROUP FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-02-27 US disclosed
US-6083961-A FOR PREVENTION AND/OR TREATMENT OF BRADYKININ OR ITS ANALOGUES MEDIATED DISEASES SUCH AS ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASE, SHOCK, PAIN FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-04 US disclosed
EP-0774462-A1 HETEROCYCLIC COMPOUND FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-05-21 EP disclosed